Related Experiment Video
Updated: Jan 13, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
DiaNat-DB-v2: A Molecular Database of Antidiabetic Compounds from Medicinal Plants and Functional Foods
Nancy De Jesús-Reyes1, Jimena García-Vázquez2, Juan F Avellaneda-Tamayo2,3
1Institute of Chemistry, Campus Merida, National Autonomous University of Mexico, Merida-Tetis Highway, Km. 4.5, Ucu, Yucatan 97357, Mexico.
Abstract:
Diabetes mellitus continues to be a significant health problem worldwide, and effective strategies and resources for its prevention and treatment are needed. Here, we present DiaNat-DB-v2, a refined and expanded version of the compound database that incorporates newly identified antidiabetic compounds from medicinal plants. By incorporating food-derived compounds, DiaNat-DB-v2 bridges the gap between medicinal chemistry and functional food research, creating new opportunities for nutraceutical development, personalized dietary interventions, and drug discovery. A comprehensive analysis of structural content, diversity, chemical space coverage, and safety-related metrics revealed that the updated database exhibits minimal overlap with FDA-approved drugs and contains a large proportion of unique molecular scaffolds, underscoring its originality and complementarity. Furthermore, the database has high natural-product likeness, a low incidence of structural alerts, and moderate compliance with classical druglikeness criteria. Together, these findings emphasize the value of DiaNat-DB-v2 as a resource for both health-oriented compound discovery and nutrition-focused research. DiaNat-DB-v2 is freely accessible as Supporting Information.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: Glinides